Compare FN & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FN | PEN |
|---|---|---|
| Founded | 1999 | 2004 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.7B | 12.9B |
| IPO Year | 2007 | 2015 |
| Metric | FN | PEN |
|---|---|---|
| Price | $662.58 | $332.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 17 |
| Target Price | ★ $489.14 | $357.33 |
| AVG Volume (30 Days) | ★ 676.2K | 509.9K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 13.21 | ★ 1155.56 |
| EPS | ★ 5.77 | 4.52 |
| Revenue | ★ $3,419,327,000.00 | $1,403,665,000.00 |
| Revenue This Year | $36.87 | $14.34 |
| Revenue Next Year | $18.16 | $13.71 |
| P/E Ratio | $119.16 | ★ $73.56 |
| Revenue Growth | ★ 18.60 | 17.50 |
| 52 Week Low | $167.33 | $221.26 |
| 52 Week High | $708.20 | $362.41 |
| Indicator | FN | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 62.63 | 46.96 |
| Support Level | $429.50 | $326.58 |
| Resistance Level | N/A | $338.99 |
| Average True Range (ATR) | 38.52 | 2.23 |
| MACD | 12.34 | 0.41 |
| Stochastic Oscillator | 79.82 | 53.94 |
Fabrinet provides advance-level optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advance optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advance-level of packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.